[go: up one dir, main page]

BR0007151A - Formulações galênicas de rápida desagregação na boca, e, processo de preparação das mesmas - Google Patents

Formulações galênicas de rápida desagregação na boca, e, processo de preparação das mesmas

Info

Publication number
BR0007151A
BR0007151A BR0007151-0A BR0007151A BR0007151A BR 0007151 A BR0007151 A BR 0007151A BR 0007151 A BR0007151 A BR 0007151A BR 0007151 A BR0007151 A BR 0007151A
Authority
BR
Brazil
Prior art keywords
agents
mouth
galenic formulations
rapid disintegration
preparing
Prior art date
Application number
BR0007151-0A
Other languages
English (en)
Inventor
Claude Laruelle
Noul Zakarian
Rene Gimet
Dominique Toselli
Original Assignee
Cll Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cll Pharma filed Critical Cll Pharma
Publication of BR0007151A publication Critical patent/BR0007151A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"FORMULAçõES GALêNICAS DE RáPIDA DESAGREGAçãO NA BOCA, E, PROCESSO DE PREPARAçãO DAS MESMAS". A invenção diz respeito à formulações galênicas de rápida desagregação na boca e a seu método de preparação. Estas formulações galênicas contém pelo menos um principio ativo disperso numa mistura de excipientes e são caracterizadas pelo fato da mistura de excipientes conter pelo menos um agente diluente de fraca compressibilidade, diferente da trealose e um copolímero da 1-vinilpirrolidina-2-ona e do acetato de vinila. Aplicações: A administração por via oral de numerosos princípios ativos (antiálgicos, agentes antiespasmódicos, agentes utilizados em gastroenterologia, agentes antienxaqueca, agentes anticefaléas, <225>-bloqueadores, agentes anti-histamínicos, agentes antibióticos, agentes anti-vertigens, agentes hipnóticos....).
BR0007151-0A 1999-09-15 2000-09-15 Formulações galênicas de rápida desagregação na boca, e, processo de preparação das mesmas BR0007151A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911513A FR2798289B1 (fr) 1999-09-15 1999-09-15 Formes galeniques a delitement rapide en bouche et leur procede de preparation
PCT/FR2000/002563 WO2001019336A1 (fr) 1999-09-15 2000-09-15 Formes galeniques a delitement rapide en bouche et leur procede de preparation

Publications (1)

Publication Number Publication Date
BR0007151A true BR0007151A (pt) 2001-08-14

Family

ID=9549849

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007151-0A BR0007151A (pt) 1999-09-15 2000-09-15 Formulações galênicas de rápida desagregação na boca, e, processo de preparação das mesmas

Country Status (18)

Country Link
US (1) US6669957B1 (pt)
EP (1) EP1131050B8 (pt)
JP (1) JP2003509353A (pt)
KR (1) KR100854033B1 (pt)
AT (1) ATE267581T1 (pt)
AU (1) AU7526300A (pt)
BR (1) BR0007151A (pt)
CA (1) CA2350675A1 (pt)
DE (1) DE60011036T2 (pt)
ES (1) ES2222234T3 (pt)
FR (1) FR2798289B1 (pt)
HU (1) HUP0104914A3 (pt)
MA (1) MA25323A1 (pt)
MX (1) MX229299B (pt)
PL (1) PL200672B1 (pt)
PT (1) PT1131050E (pt)
WO (1) WO2001019336A1 (pt)
ZA (1) ZA200103280B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US20050220873A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
US20050220874A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist
US20050226927A1 (en) * 2004-04-02 2005-10-13 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
TWI338583B (en) * 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
JP5112619B2 (ja) * 2004-05-20 2013-01-09 大塚製薬株式会社 固形医薬製剤
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
WO2006135491A2 (en) * 2005-06-08 2006-12-21 Basf Aktiengesellschaft Medicament carrier composition and method of forming a film therefrom
CN101277701A (zh) * 2005-09-30 2008-10-01 贝林格尔·英格海姆维特梅迪卡有限公司 含有美洛昔康的药物制剂
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
BRPI0819824A2 (pt) * 2007-11-14 2014-10-07 Manuel Gidekel Novos extratos de deschampsia antartica desv. com atividade antineoplásica
US8617588B2 (en) 2009-03-09 2013-12-31 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
IN2012DN03157A (pt) * 2009-10-12 2015-09-18 Boehringer Ingelheim Vetmed
EP2314296A1 (en) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally Disintegrating Tablets of Betahistine
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CN105188756B (zh) * 2013-11-13 2020-06-12 财团法人教育研究基金会 无肝副作用的对乙酰胺基酚新复方组合
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成
FR3099881B1 (fr) 2019-08-13 2022-08-26 Ethypharm Sa Comprimé orodispersible d’opioide à faible dosage et son procédé de préparation.
WO2024187116A2 (en) * 2023-03-08 2024-09-12 Cornell University Thermophobic trehalose glycopolymers as smart c-type lectin receptor vaccine adjuvants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
EP0879048B2 (en) * 1996-02-09 2009-07-29 Quadrant Drug Delivery Limited Method for making tablets using trehalose
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof

Also Published As

Publication number Publication date
ATE267581T1 (de) 2004-06-15
KR100854033B1 (ko) 2008-08-26
PL200672B1 (pl) 2009-01-30
HUP0104914A3 (en) 2003-05-28
AU7526300A (en) 2001-04-17
US6669957B1 (en) 2003-12-30
ES2222234T3 (es) 2005-02-01
FR2798289A1 (fr) 2001-03-16
FR2798289B1 (fr) 2004-12-31
EP1131050B1 (fr) 2004-05-26
KR20010089883A (ko) 2001-10-12
WO2001019336A1 (fr) 2001-03-22
JP2003509353A (ja) 2003-03-11
ZA200103280B (en) 2001-10-25
MA25323A1 (fr) 2001-12-31
DE60011036D1 (de) 2004-07-01
EP1131050A1 (fr) 2001-09-12
EP1131050B8 (fr) 2004-11-10
MX229299B (es) 2005-07-20
CA2350675A1 (fr) 2001-03-22
PL347693A1 (en) 2002-04-22
PT1131050E (pt) 2004-11-30
DE60011036T2 (de) 2005-06-23
HUP0104914A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
BR0007151A (pt) Formulações galênicas de rápida desagregação na boca, e, processo de preparação das mesmas
CA2400317A1 (en) Improved paste formulations
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
PT861084E (pt) Processo e composicao melhorados para cisplatina (cddp) terapeutica
WO2001058474A3 (en) Microencapsulation and sustained release of biologically active agent
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
BR0111016A (pt) Composições farmacêuticas de liberação sustentada para a administração parenteral de compostos hidrófilos biologicamente ativos
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
BR9901782A (pt) Forma para dosagem de nefazodona.
MXPA03001762A (es) Proceso para preparar composiciones farmaceuticas para uso con formulaciones de gelatina suave.
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
MY124599A (en) Oral suspension of pharmaceutical substance
WO1999061014A3 (en) Compositions and methods employing r(-) fluoxetine and other active ingredients
SE0001916D0 (sv) Novel formulation
GEP20043377B (en) Pharmaceutical Complex
RS50074B (sr) Farmaceutski preparat koji sadrži paracetamol i drotaverin
MXPA04002099A (es) Composiciones medicinales para neuropatia diabetica.
BR0005319A (pt) Tratamento combinado para depressão e ansiedade
PT1108431E (pt) Preparacoes farmaceuticas gastro-resistentes multiunitarias contendo piroxicam
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations
AU7533394A (en) Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]